Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

27-Aug-16 - 25-Aug-17
Buy Ratio:43%

Up

# Net Buyers:136
# Net Sellers:182

Previous 52 Weeks

29-Aug-15 - 26-Aug-16
Buy Ratio:40%
# Net Buyers:136
# Net Sellers:202
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($14.63M)$1.56B  
Zoetis Inc.($7.28M)$781.53M  
Colucid Pharmaceuticals, Inc.$714.41M$717.19M  
Anacor Pharmaceuticals, Inc.--$236.04M  
Lilly Eli & Co($129.20M)$176.05M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$714.41M$717.19M  
Tobira Therapeutics, Inc.$72.30M$80.44M  
Alnylam Pharmaceuticals, Inc.$12.84M$27.76M  
Amicus Therapeutics Inc$18.96M$21.43M  
Medicines Co /de$17.38M$19.39M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.82B)  
Seattle Genetics Inc /wa$114.89M($324.14M)  
Incyte Corp($51.03M)($270.06M)  
Catalent, Inc.($414.44M)($196.62M)  
Acadia Pharmaceuticals Inc($11.26M)($165.62M)  
New Net Sellers
CompanyNet Buy AmountChange
Incyte Corp($51.03M)($270.06M)  
Acadia Pharmaceuticals Inc($11.26M)($165.62M)  
Global Blood Therapeutics, Inc.($97.63M)($97.68M)  
Nexvet Biopharma Plc($76.62M)($78.36M)  
Biogen Inc.($1.77M)($75.70M)